Johnson & Johnson (JNJ) has quietly ground higher, with the stock up roughly 7% over the past month and nearly 14% in the past 3 months, drawing fresh attention from income focused investors. See our ...
Zacks Investment Research on MSN
Johnson & Johnson (JNJ) stock drops despite market gains: Important facts to note
Johnson & Johnson (JNJ) closed the most recent trading day at $202.48, moving -1.39% from the previous trading session. This change lagged the S&P 500's daily gain of 0.11%. Meanwhile, the Dow ...
After years of post-COVID-19 normalization and the impact of its Kenvue spinoff, Johnson & Johnson’s (NYSE: JNJ) stock price is back in rally mode. It is still early in the game, but the Q2 results ...
Johnson & Johnson stock rises on strong earnings, the Halda deal, FDA wins and an upcoming orthopedics spinoff as analysts weigh the outlook.
Zacks Investment Research on MSN
JNJ vs. PFE: Which blue-chip drug stock is the better investment now?
Johnson & Johnson JNJ and Pfizer PFE are both healthcare leaders with large drug portfolios and diversified revenue streams, ...
Johnson & Johnson (NYSE:JNJ – Free Report) had its target price lifted by Bank of America from $161.00 to $175.00 in a report issued on Thursday morning,Benzinga reports. The brokerage currently has a ...
Last month, Johnson & Johnson surged following a well-received quarterly earnings release. Despite a sluggish start to November, a spate of positive news has since sent the healthcare stock's shares ...
If you bought 10 shares of Johnson & Johnson (JNJ) stock 10 years ago, this is how much it would be worth today.
Members of Congress have traded $JNJ stock 22 times in the past 6 months. Of those trades, 11 have been purchases and 11 have been sales. Here’s a breakdown of ...
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results